BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 18645103)

  • 1. Effect of multiple-nodal basin drainage on cutaneous melanoma.
    Federico AC; Chagpar AB; Ross MI; Martin RC; Noyes RD; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Sussman JJ; McMasters KM; Scoggins CR;
    Arch Surg; 2008 Jul; 143(7):632-7; discussion 637-8. PubMed ID: 18645103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of multiple lymphatic basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy.
    McHugh JB; Su L; Griffith KA; Schwartz JL; Wong SL; Cimmino V; Chang AE; Johnson TM; Sabel MS
    Ann Surg Oncol; 2006 Sep; 13(9):1216-23. PubMed ID: 16952026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of drainage and recurrence following sentinel lymph node biopsy for cutaneous melanoma of the head and neck.
    Fincher TR; O'Brien JC; McCarty TM; Fisher TL; Preskitt JT; Lieberman ZH; Stephens JF; Kuhn JA
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):844-8. PubMed ID: 15262761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microscopic satellitosis in patients with primary cutaneous melanoma: implications for nodal basin staging.
    Kimsey TF; Cohen T; Patel A; Busam KJ; Brady MS
    Ann Surg Oncol; 2009 May; 16(5):1176-83. PubMed ID: 19224283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic information from sentinel lymph node biopsy in patients with thick melanoma.
    Scoggins CR; Bowen AL; Martin RC; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; Hagendoorn L; McMasters KM
    Arch Surg; 2010 Jul; 145(7):622-7. PubMed ID: 20644123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reevaluation of the locoregional recurrence rate in melanoma patients with a positive sentinel node compared to patients with palpable nodal involvement.
    Veenstra HJ; van der Ploeg IM; Wouters MW; Kroon BB; Nieweg OE
    Ann Surg Oncol; 2010 Feb; 17(2):521-6. PubMed ID: 19898903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
    Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
    Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.
    Callender GG; Egger ME; Burton AL; Scoggins CR; Ross MI; Stromberg AJ; Hagendoorn L; Martin RC; McMasters KM
    Am J Surg; 2011 Dec; 202(6):659-64; discussion 664-5. PubMed ID: 22137134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
    Roka F; Kittler H; Cauzig P; Hoeller C; Hinterhuber G; Wolff K; Pehamberger H; Diem E
    Br J Cancer; 2005 Feb; 92(4):662-7. PubMed ID: 15700039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
    Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An increased number of sentinel lymph nodes is associated with advanced Breslow depth and lymphovascular invasion in patients with primary melanoma.
    Schmidt CR; Panageas KS; Coit DG; Patel A; Brady MS
    Ann Surg Oncol; 2009 Apr; 16(4):948-52. PubMed ID: 19194758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma.
    Caracò C; Marone U; Celentano E; Botti G; Mozzillo N
    Ann Surg Oncol; 2007 Sep; 14(9):2662-7. PubMed ID: 17597345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Full-thickness grafts procured from skin overlying the sentinel lymph node basin; reconstruction of primary cutaneous malignancy excision defects.
    Lewis JM; Zager JS; Yu D; Pelaez D; Riker AI; Dessureault S; Cruse CW; Reintgen DS; Puleo CA; Sondak VK
    Ann Surg Oncol; 2008 Jun; 15(6):1733-40. PubMed ID: 18379848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study.
    Wong SL; Morton DL; Thompson JF; Gershenwald JE; Leong SP; Reintgen DS; Gutman H; Sabel MS; Carlson GW; McMasters KM; Tyler DS; Goydos JS; Eggermont AM; Nieweg OE; Cosimi AB; Riker AI; G Coit D
    Ann Surg Oncol; 2006 Jun; 13(6):809-16. PubMed ID: 16604476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma.
    McMasters KM; Edwards MJ; Ross MI; Reintgen DS; Martin RC; Urist MM; Noyes RD; Sussman JJ; Stromberg AJ; Scoggins CR
    Ann Surg; 2010 Sep; 252(3):460-5; discussion 465-6. PubMed ID: 20739846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
    Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E
    Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.